Aquestive Therapeutics, Inc. (AQST) vs Tilray Brands, Inc. (TLRY)
- Aquestive Therapeutics, Inc. AQST 3.78 −6.90%
- Tilray Brands, Inc. TLRY 3.04 −5.30%
Aquestive Therapeutics, Inc. and Tilray Brands, Inc. are both Drug Manufacturers Specialty & Generic companies. Aquestive Therapeutics, Inc. and Tilray Brands, Inc. are of similar size ($509.6M and $474.4M). Aquestive Therapeutics, Inc. grew revenue faster over the last twelve months: 22.6% against 15.9%. Tilray Brands, Inc. has the higher net margin (−17.1% vs −144.6%) and the lower return on invested capital (−3.21% vs 0.00%). Across the 17 metrics below, Aquestive Therapeutics, Inc. leads on 9 and Tilray Brands, Inc. on 8.
Valuation
Profitability
| Metric | AQST | TLRY | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 67.04% | 29.12% | 53.94% |
| Operating margin | (97.52%) | (9.26%) | 0.00% |
| Net margin | (144.63%) | (17.05%) | 0.00% |
| Free cash flow margin | (84.95%) | (18.11%) | 0.00% |
| Return on equity | 121.12% | (10.50%) | (0.40%) |
| Return on assets | (69.29%) | (7.45%) | (3.32%) |
| Return on invested capital | 0.00% | (3.21%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack